Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Is Nutrien (NTR) Stock Undervalued Right Now?
Is Nutrien (NTR) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Should Value Investors Buy Textron (TXT) Stock?
Should Value Investors Buy Textron (TXT) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the

Is Iberdrola (IBDRY) Stock Outpacing Its Utilities Peers This Year?
Is Iberdrola (IBDRY) Stock Outpacing Its Utilities Peers This Year?

For those looking to find strong Utilities stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Iberdrola S.A. (IBDRY) one of those stocks right now

Why Akamai Technologies (AKAM) is a Top Value Stock for the Long-Term
Why Akamai Technologies (AKAM) is a Top Value Stock for the Long-Term

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

Should Value Investors Buy Johnson Matthey (JMPLY) Stock?
Should Value Investors Buy Johnson Matthey (JMPLY) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the

Is Bowman Consulting Group (BWMN) Stock Outpacing Its Business Services Peers This Year?
Is Bowman Consulting Group (BWMN) Stock Outpacing Its Business Services Peers This Year?

The Business Services group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Bowman Consulting (BWMN) is a stock that can

Company News for Aug 19, 2025
Company News for Aug 19, 2025
  • First Solar, Inc.’s FSLR shares jumped 9.7% on the U.S. Treasury Department's unveiling of new and less restrictive than expected federal tax subsidy rules for solar and wind projects.
  • Shares of
Stock Market News for Aug 19, 2025
Stock Market News for Aug 19, 2025

Wall Street closed flat on Monday, pulled down by energy and real estate stocks. Investor mood remained muted and cautious as they eagerly await Fed Chair Jerome Powell’s comments at the Jackson

Can BigBear.ai Capitalize on $320B National Security Funding Tailwind?
Can BigBear.ai Capitalize on $320B National Security Funding Tailwind?

BigBear.ai Holdings, Inc. BBAI is entering a pivotal phase as sweeping federal investments reshape the defense technology landscape. The recently passed One Big Beautiful Bill (OB3) allocates nearly

Down 23.3% in 4 Weeks, Here's Why Freightcar America (RAIL) Looks Ripe for a Turnaround
Down 23.3% in 4 Weeks, Here's Why Freightcar America (RAIL) Looks Ripe for a Turnaround

A downtrend has been apparent in Freightcar America (RAIL) lately with too much selling pressure. The stock has declined 23.3% over the past four weeks. However, given the fact that it is now in

Down 17.7% in 4 Weeks, Here's Why Spero Therapeutics (SPRO) Looks Ripe for a Turnaround
Down 17.7% in 4 Weeks, Here's Why Spero Therapeutics (SPRO) Looks Ripe for a Turnaround

A downtrend has been apparent in Spero Therapeutics, Inc. (SPRO) lately with too much selling pressure. The stock has declined 17.7% over the past four weeks. However, given the fact that it is now

Shoals Technologies Group (SHLS) Just Overtook the 20-Day Moving Average
Shoals Technologies Group (SHLS) Just Overtook the 20-Day Moving Average

From a technical perspective, Shoals Technologies Group (SHLS) is looking like an interesting pick, as it just reached a key level of support. SHLS recently overtook the 20-day moving average, and

Down 21.7% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround
Down 21.7% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround

Soleno Therapeutics, Inc. (SLNO) has been on a downward spiral lately with significant selling pressure. After declining 21.7% over the past four weeks, the stock looks well positioned for a trend

Will EXEL's Share Repurchase Program Boost Value for Investors?
Will EXEL's Share Repurchase Program Boost Value for Investors?

Exelixis (EXEL) has been consistently repurchasing shares in the past couple of years to boost shareholders’ gain.

Share repurchases reduce the number of shares outstanding, thereby boosting the

The Zacks Analyst Blog Highlights IBM, Goldman Sachs Group and Thermo Fisher Scientific
The Zacks Analyst Blog Highlights IBM, Goldman Sachs Group and Thermo Fisher Scientific

For Immediate Release

Chicago, IL – August 19, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

Strategic Partnerships Power Tempus AI's Healthcare Expansion
Strategic Partnerships Power Tempus AI's Healthcare Expansion

Tempus AI, Inc. TEM is rapidly expanding its partnerships across oncology and neuroscience, leveraging its AI platforms — Lens and Next — to accelerate precision medicine.

Tempus has entered into a

Wall Street Analysts Think CrowdStrike (CRWD) Is a Good Investment: Is It?
Wall Street Analysts Think CrowdStrike (CRWD) Is a Good Investment: Is It?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Brokers Suggest Investing in High Tide (HITI): Read This Before Placing a Bet
Brokers Suggest Investing in High Tide (HITI): Read This Before Placing a Bet

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Brokers Suggest Investing in Nutanix (NTNX): Read This Before Placing a Bet
Brokers Suggest Investing in Nutanix (NTNX): Read This Before Placing a Bet

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Wall Street Analysts Think Applied Materials (AMAT) Is a Good Investment: Is It?
Wall Street Analysts Think Applied Materials (AMAT) Is a Good Investment: Is It?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Is Bit Digital (BTBT) a Buy as Wall Street Analysts Look Optimistic?
Is Bit Digital (BTBT) a Buy as Wall Street Analysts Look Optimistic?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Here's What Key Metrics Tell Us About Viking (VIK) Q2 Earnings
Here's What Key Metrics Tell Us About Viking (VIK) Q2 Earnings

For the quarter ended June 2025, Viking Holdings (VIK) reported revenue of $1.88 billion, up 18.5% over the same period last year. EPS came in at $0.99, compared to $0.76 in the year-ago quarter.

Earnings Growth & Price Strength Make Goldman Sachs (GS) a Stock to Watch
Earnings Growth & Price Strength Make Goldman Sachs (GS) a Stock to Watch

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.

The Zacks Premium